TUMOR NECROSIS FACTOR CAN INDUCE FEVER IN RATS WITHOUT ACTIVATING PROTEIN BREAKDOWN IN MUSCLE OR LIPOLYSIS IN ADIPOSE-TISSUE

被引:132
作者
KETTELHUT, IC
GOLDBERG, AL
机构
关键词
D O I
10.1172/JCI113467
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:1384 / 1389
页数:6
相关论文
共 46 条
[1]  
AGARRWAL BB, 1985, J BIOL CHEM, V260, P2345
[2]   CHARACTERIZATION OF RECEPTORS FOR HUMAN-TUMOR NECROSIS FACTOR AND THEIR REGULATION BY GAMMA-INTERFERON [J].
AGGARWAL, BB ;
EESSALU, TE ;
HASS, PE .
NATURE, 1985, 318 (6047) :665-667
[3]  
ATKINS E, 1985, PHYSL METABOLIC IMMU, P97
[4]   STIMULATION OF MUSCLE PROTEIN-DEGRADATION AND PROSTAGLANDIN-E2 RELEASE BY LEUKOCYTIC PYROGEN (INTERLEUKIN-1) - A MECHANISM FOR THE INCREASED DEGRADATION OF MUSCLE PROTEINS DURING FEVER [J].
BARACOS, V ;
RODEMANN, HP ;
DINARELLO, CA ;
GOLDBERG, AL .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (10) :553-558
[5]   PURIFICATION OF CACHECTIN, A LIPOPROTEIN-LIPASE SUPPRESSING HORMONE SECRETED BY ENDOTOXIN-INDUCED RAW 264.7 CELLS [J].
BEUTLER, B ;
MAHONEY, J ;
LETRANG, N ;
PEKALA, P ;
CERAMI, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 161 (05) :984-995
[6]   CACHECTIN AND TUMOR-NECROSIS-FACTOR AS 2 SIDES OF THE SAME BIOLOGICAL COIN [J].
BEUTLER, B ;
CERAMI, A .
NATURE, 1986, 320 (6063) :584-588
[7]   IDENTITY OF TUMOR NECROSIS FACTOR AND THE MACROPHAGE-SECRETED FACTOR CACHECTIN [J].
BEUTLER, B ;
GREENWALD, D ;
HULMES, JD ;
CHANG, M ;
PAN, YCE ;
MATHISON, J ;
ULEVITCH, R ;
CERAMI, A .
NATURE, 1985, 316 (6028) :552-554
[8]   PASSIVE-IMMUNIZATION AGAINST CACHECTIN TUMOR NECROSIS FACTOR PROTECTS MICE FROM LETHAL EFFECT OF ENDOTOXIN [J].
BEUTLER, B ;
MILSARK, IW ;
CERAMI, AC .
SCIENCE, 1985, 229 (4716) :869-871
[9]   ENDOTOXIN-INDUCED SERUM FACTOR THAT CAUSES NECROSIS OF TUMORS [J].
CARSWELL, EA ;
OLD, LJ ;
KASSEL, RL ;
GREEN, S ;
FIORE, N ;
WILLIAMSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (09) :3666-3670
[10]  
Cerami A., 1983, Mechanism of drug action. (Proceedings of a Symposium on the biochemical basis of drug action, Stanford University, California, 20-23 June 1983), P175